Login / Signup

Suggestions for the predictive factors related to irAES and research methods during dose switching of pembrolizumab treatment in patients with advanced NSCLC.

Zelu HanLingshuang LiuYi Jiang
Published in: Journal of thoracic oncology : official publication of the International Association for the Study of Lung Cancer (2024)
Keyphrases
  • advanced non small cell lung cancer
  • small cell lung cancer
  • combination therapy
  • brain metastases
  • replacement therapy
  • tyrosine kinase